VistaGen
Therapeutics, a biotech company using proprietary pluripotent stem cell
technology for drug rescue and regenerative medicine, has received from the
Canadian Intellectual Property Office a Notice of Allowance for Canadian patent
No. 2,684,022, entitled “Mesoderm and Definitive Endoderm Cell Populations.”
This patent, which
is exclusively licensed to VistaGen by the Icahn School of Medicine at Mount
Sinai in New York, will expand VistaGen’s intellectual property portfolio for
pluripotent stem cell culture systems that produce human cells of the endoderm
lineage, including liver, lung, pancreas, parathyroid and thyroid cells. The
patent enables the company to extend its research into the Canadian market and
follows the company’s recently awarded U.S. patent.
“This important
Canadian patent allowance extends our core intellectual property protection in
a market that has been strategically significant to us for many years,” Shawn
K. Singh, JD, VistaGen’s chief executive officer, stated in the news release.
“In a manner similar to our recently announced Notice of Allowance for its
counterpart, U.S. Patent Application 12/836,275, this new Canadian patent
allowance and our world-class differentiation and assay formulation expertise
put us in a strong position to pursue additional stem cell research projects in
Canada, especially innovative projects involving liver biology, customized drug
metabolism assays, and pilot nonclinical studies using pancreatic beta-islet
cells for drug and regenerative cell therapies for diabetes.”
For more information
visit http://www.vistagen.com/
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment